INS and type 2 diabetes mellitus: Recent studies support the clinical utility of initiating insulin therapy early in patients with T2D by adding a single injection of basal insulin to an existing oral regimen in order to achieve and maintain target hemoglobin A1C (HbA1c) levels ≤7% [4–8].